Edition:
United States

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

27.98USD
21 Sep 2018
Change (% chg)

$-0.94 (-3.25%)
Prev Close
$28.92
Open
$29.07
Day's High
$29.07
Day's Low
$27.37
Volume
183,144
Avg. Vol
81,153
52-wk High
$40.60
52-wk Low
$15.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 18.32 -0.754
Mar '18 17.11 -0.445
FY 2017 Dec '17 18.04 -0.349
Sep '17 13.45 -0.263
Jun '17 5.71 -0.705
Mar '17 6.09 -2.211
FY 2016 Dec '16 0.00 -1.171
Sep '16 0.00 -0.686
Jun '16 0.00 -0.471
Mar '16 0.00 -0.552
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 19.82 37.40 10.00 37.40
Quarter Ending Dec-18 5 42.99 90.70 18.90 37.40
Year Ending Dec-18 5 98.34 164.00 71.40 76.10
Year Ending Dec-19 5 366.94 874.00 100.90 299.81
Earnings (per share)
Quarter Ending Sep-18 5 -0.79 -0.56 -0.89 --
Quarter Ending Dec-18 5 -0.58 0.03 -0.94 --
Year Ending Dec-18 5 -2.57 -1.70 -3.10 -1.01
Year Ending Dec-19 5 -0.62 5.88 -3.33 0.84
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.48 32.69
P/E High - Last 5 Yrs. -- 42.01 47.23
P/E Low - Last 5 Yrs. -- 23.55 24.79
Beta -- 0.90 0.87
Price to Sales (TTM) 35.84 4.40 6.46
Price to Book (MRQ) 8.26 3.53 3.90
Price to Tangible Book (MRQ) 8.31 5.08 5.96
Price to Cash Flow (TTM) -- 22.16 23.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.83 1.69
Dividend Yield - 5 Year Avg -- 1.53 1.45
Dividend 5 Year Growth Rate -- -8.56 -5.70
Payout Ratio(TTM) -- 49.41 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 220.69 5.62 8.38
Sales (TTM) vs TTM 1 Yr. Ago 466.73 4.61 6.69
Sales - 5 Yr. Growth Rate -- 6.93 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago -6.93 18.77 25.56
EPS (TTM) vs TTM 1 Yr. Ago 62.06 -- --
EPS - 5 Yr. Growth Rate -- 6.47 7.60
Capital Spending - 5 Yr. Growth Rate -- 7.80 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.19 2.19
Current Ratio (MRQ) 4.00 2.93 2.97
LT Debt to Equity (MRQ) 0.00 8.97 11.24
Total Debt to Equity (MRQ) 0.00 11.26 14.06
Interest Coverage (TTM) -126.46 41.23 35.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.11 54.67
Gross Margin - 5 Yr. Avg. -- 53.34 53.30
EBITD Margin (TTM) -195.82 -- --
EBITD - 5 Yr. Avg -- 18.71 15.88
Operating Margin (TTM) -196.17 13.28 3.65
Operating Margin - 5 Yr. Avg. -- 14.29 11.00
Pre-Tax Margin (TTM) -190.75 13.67 3.97
Pre-Tax Margin - 5 Yr. Avg. -- 14.59 11.19
Net Profit Margin (TTM) -192.98 10.29 0.70
Net Profit Margin - 5 Yr. Avg. -- 10.88 7.52
Effective Tax Rate (TTM) -- 20.47 20.44
Effective Tax Rate - 5 Yr. Avg. -- 23.83 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 669,140 820,431,328 714,979,821
Net Income/Employee (TTM) -1,291,280 94,873,964 82,568,832
Receivable Turnover (TTM) -- 5.00 5.01
Inventory Turnover (TTM) -- 2.52 3.61
Asset Turnover (TTM) 0.26 0.83 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -49.75 10.03 9.75
Return on Assets - 5 Yr. Avg. -- 11.38 10.91
Return on Investment (TTM) -73.19 13.04 12.72
Return on Investment - 5 Yr. Avg. -- 14.69 14.03
Return on Equity (TTM) -240.41 14.99 14.85
Return on Equity - 5 Yr. Avg. -- 15.90 15.38
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -25.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akcea Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -14.25 -15.86 10 43
13 Week 6.71 0.35 61 72
26 Week -12.56 -22.75 34 52
52 Week 5.94 -9.57 55 37
YTD 61.18 47.09 90 41
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.76%
# of Holders: 90
Total Shares Held: 22,935,834
3 Mo. Net Change: 2,239,897
# New Positions: 8
# Closed Positions: 12
# Increased Positions: 42
# Reduced Positions: 43
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.